首页> 外文OA文献 >Efficacy of aflibercept on exudative age-related macular degeneration in patients exhibiting complete ranibizumab resistance and tachyphylaxis

【2h】

Efficacy of aflibercept on exudative age-related macular degeneration in patients exhibiting complete ranibizumab resistance and tachyphylaxis

机译：阿柏西普对表现出完全雷珠单抗耐药和快速耐受的患者渗出性年龄相关性黄斑变性的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gokcen Gokce; Ali Hakan Durukan; Mehmet Talay Koylu; Murat Kucukevcilioglu;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of aflibercept on exudative age-related macular degeneration in patients exhibiting complete ranibizumab resistance and tachyphylaxis [J] . Gokcen Gokce, Murat Kucukevcilioglu, Ali Hakan Durukan, Arquivos Brasileiros de Oftalmologia . 2016,第6期

机译：阿柏西普对具有完全雷珠单抗抗性和速激肽反应的患者与渗出性年龄相关的黄斑变性的疗效
2. A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] [J] . Clinical ophthalmology . 2017,第8期

机译：由研究者发起的单臂研究，用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效，安全性和耐受性（ASSESS研究）：12个月分析[更正]
3. A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-mo [J] . Rishi P Singh, Sunil K Srivastava, Justis P Ehlers, Clinical ophthalmology . 2015,第7期

机译：由研究者发起的单臂研究，用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效，安全性和耐受性（ASSESS研究）：12个月
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. A single-arm investigator-initiated study of the efficacy safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis Corrigendum [O] . 2017

机译：由研究人员发起的单臂研究用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效安全性和耐受性（ASSESS研究）：12个月分析更正
7. >Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration [O] . Naoko Koike, Tsuyoshi Otsuji, Akiko Tsumura, 2019

机译：>雷尼兹努接收对患者的转折结果与渗出的年龄相关性黄斑变性的患者（患者）

Efficacy of aflibercept on exudative age-related macular degeneration in patients exhibiting complete ranibizumab resistance and tachyphylaxis

著录项

相似文献

相关主题

期刊订阅